GlobalSurg-CovidSurg Week
- Conditions
- SurgeryCovid19Post-Op Complication
- Registration Number
- NCT04509986
- Lead Sponsor
- University of Birmingham
- Brief Summary
Observational study to determine the optimal timing for surgery following SARS-CoV-2 infection and assess key global surgery indicators.
- Detailed Description
* Prospective, observational international cohort study.
* Any hospital worldwide can participate (including hospitals that have not admitted SARS-CoV-2 infected patients).
* All patients undergoing a surgical procedure in an operating theatre will be included. All consecutive eligible patients should be included.
* 7-day data collection period, with follow-up at 30 days after surgery for each patient. However, no changes should be made to normal patient care/ follow-up pathways
* Primary outcome is 30-day mortality.
* All collaborators will be included as PubMed-citable co-authors on resulting publications.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 1000
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Post-operative mortality 30 days after surgery Mortality at 30 days after surgery
- Secondary Outcome Measures
Name Time Method In-patient mortality 30 days after surgery Mortality while the patient is admitted to hospital
Post-operative complications 30 days after surgery 30-day Clavien-Dindo grade
Post-operative pulmonary complications 30 days after surgery 30-day postoperative pulmonary complications (pneumonia \[CDC definition\], ARDS, unexpected ventilation)
Post-operative venous thromboembolism 30 days after surgery 30-day venous thromboembolism (deep vein thrombosis/ pulmonary embolism)